Prokarium Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.prokarium.com
Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer
Phase 1
Active, not recruiting
- Conditions
- Non Muscle Invasive Bladder CancerNMIBCHigh Risk NMIBC
- Interventions
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- Prokarium Ltd
- Target Recruit Count
- 22
- Registration Number
- NCT06181266
- Locations
- 🇺🇸
Michael G. Oefelein Clinical Trials, Bakersfield, California, United States
🇺🇸Duke Health-Duke Cancer Center, Durham, North Carolina, United States
🇺🇸Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina, United States
Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine
Phase 1
Completed
- Conditions
- Enteric Fever
- Interventions
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Prokarium Ltd
- Target Recruit Count
- 46
- Registration Number
- NCT04349553
- Locations
- 🇬🇧
Simbec Research, Merthyr Tydfil, Wales, United Kingdom
News
No news found